Carbohydrate antigen 125

  • S. HoldenriederEmail author
  • P. Stieber
Living reference work entry
Part of the Springer Reference Medizin book series (SRM)


Carbohydrate antigen 125


  1. Lamerz R (2012) CA 125. In: Thomas L (Hrsg) Labor und Diagnose, 8. Aufl. TH-Books, Frankfurt am Main, S 1634–1639Google Scholar
  2. Moore RG et al (2014) Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer. Gynecol Oncol 135:547–551CrossRefPubMedGoogle Scholar
  3. Sölétormos G et al (2016) Clinical use of cancer biomarkers in epithelial ovarian cancer: updated guidelines from the European group on tumor markers. Int J Gynecol Cancer 26:43–51CrossRefPubMedGoogle Scholar
  4. Sturgeon CM, Duffy MJ, Stenman UH et al (2008) National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 54:e11–e79CrossRefPubMedGoogle Scholar
  5. Trapé J et al (2011) Increased plasma concentrations of tumour markers in the absence of neoplasia. Clin Chem Lab Med 49:1605–1620CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Institut für LaboratoriumsmedizinDeutsches Herzzentrum München, Klinik an der Technischen Universität MünchenMünchenDeutschland
  2. 2.Institut für Laboratoriumsmedizin Klinikum der Universität München (LMU)MünchenDeutschland

Personalised recommendations